Covered recipient · General Payments record
DONALD RICHARD COLLINS
Allopathic & Osteopathic Physicians Plastic Surgery
General Payments · PY2018–2024
$7,291.90
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,023.50 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MOTIVA USA, LLC | $270.45 | 2 |
| ABBVIE INC. | $230.12 | 4 |
| Musculoskeletal Transplant Foundation Inc. | $148.89 | 2 |
| Ethicon US, LLC | $116.42 | 1 |
| Medtronic, Inc. | $80.41 | 1 |
| Mentor Worldwide LLC | $72.22 | 1 |
| Alafair Biosciences, Inc. | $41.34 | 1 |
| REVANCE THERAPEUTICS, INC. | $35.29 | 1 |
| AXOGEN | $28.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.59 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491897 | CMS |
| ABBVIE INC. | $33.02 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491899 | CMS |
| ABBVIE INC. | $31.94 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491901 | CMS |
| ABBVIE INC. | $131.57 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491903 | CMS |
| Alafair Biosciences, Inc. | $41.34 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138674802 | CMS |
| AXOGEN | $28.36 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143640092 | CMS |
| Ethicon US, LLC | $116.42 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077648146 | CMS |
| Medtronic, Inc. | $80.41 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117134004 | CMS |
| Mentor Worldwide LLC | $72.22 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077619258 | CMS |
| MOTIVA USA, LLC | $136.30 | 09/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139154464 | CMS |
| MOTIVA USA, LLC | $134.15 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139154728 | CMS |
| Musculoskeletal Transplant Foundation Inc. | $27.82 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128569451 | CMS |
| Musculoskeletal Transplant Foundation Inc. | $121.07 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128570637 | CMS |
| REVANCE THERAPEUTICS, INC. | $35.29 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147915069 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.